Put companies on watchlist
Cherry SE
ISIN: DE000A3CRRN9
WKN: A3CRRN
Curious about what AI knows about Cherry? Just one click more
More AI Integrations
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

Cherry SE · ISIN: DE000A3CRRN9 · EQS - Company News (108 News)
Country: Germany · Primary market: Germany · EQS NID: 2137520
14 May 2025 01:06PM

Cherry SE publishes Q1 2025 report and reaffirms full-year guidance


EQS-News: Cherry SE / Key word(s): Quarterly / Interim Statement
Cherry SE publishes Q1 2025 report and reaffirms full-year guidance

14.05.2025 / 13:06 CET/CEST
The issuer is solely responsible for the content of this announcement.


Munich, 14 May 2025 – Cherry SE [ISIN: DE000A3CRRN9], a global manufacturer of computer input devices and digital solutions for the healthcare sector, today published its first quarter 2025 report and reaffirmed full-year guidance.

In the first quarter of 2025, Cherry SE generated Group revenue of EUR 25.3 million. Adjusted earnings before interest, taxes, depreciation, and amortization (adjusted EBITDA) amounted to EUR -2.0 million, corresponding to an adjusted EBITDA margin of -8.0%. While the results were in line with the company’s own expectations, they were below the figures reported in the same period of the previous year (Q1 2024 Group revenue: EUR 30.3 million; adjusted EBITDA margin: 2.8%).

The macroeconomic environment remained challenging in Q1 2025, shaped by continued economic weakness in Germany and market uncertainty related to anticipated increases in U.S. tariffs on Chinese goods.

Business Segment Performance in Q1 2025

  • GAMING & OFFICE PERIPHERALS: Revenue of EUR 19.1 million (Q1 2024: EUR 20.6 million) with an adjusted EBITDA margin of 10.5% (Q1 2024: 10.6%). Sales were impacted by high inventory levels in Germany and a weaker-than-expected performance in the U.S. market. In contrast, China recorded a solid sales performance.
  • DIGITAL HEALTH & SOLUTIONS: Revenue amounted to EUR 4.8 million (Q1 2024: EUR 8.0 million), with an adjusted EBITDA margin of 17.6% (Q1 2024: 32.2%). The year-over-year decline reflects a strong prior-year base due to the rollout of e-prescriptions and the delayed introduction of the electronic patient file in the current year.
  • COMPONENTS: Revenue totaled EUR 1.5 million (Q1 2024: EUR 1.7 million), with an adjusted EBITDA margin of -22.5% (Q1 2024: 21.1%). The market environment remained highly challenging due to intense price competition.

Restructuring and Strategic Measures

On 22 April 2025, Cherry SE announced its decision to discontinue switch production at its Auerbach site and fully relocate it to a partner in China as part of a comprehensive restructuring plan. The Auerbach location will be retained and is to be transformed into a development, logistics, and service hub.

In parallel, Cherry SE reached an agreement with UniCredit Bank GmbH to extend its existing loan facility under adjusted terms until the end of 2027. Additionally, on 8 May 2025, the company announced the sale of its hygienic input device business (formerly Active Key) to Contour Design Nordic A/S. The transaction has a total value of EUR 21 million, consisting of fixed and performance-based components.

Outlook for the 2025 Financial Year

The Management Board confirms its forecast for the 2025 financial year, expecting Group revenue in the range of EUR 105 to 120 million and an adjusted EBITDA margin between 3.0% and 6.0%.

Oliver Kaltner, CEO of Cherry SE, commented: “The results of the first quarter reflect the market conditions we had anticipated in our internal business plan. We are confident that the restructuring measures we have initiated, along with the continued focus on strengthening our core businesses, will enable us to navigate current challenges and return to profitable growth. The divestment of the Active Key division provides us with additional flexibility.”

Further Information
The full Q1 2025 quarterly financial report is available for download on the Investor Relations section of the Cherry SE website.

 

About Cherry SE

Cherry SE [ISIN: DE000A3CRRN9] is a global manufacturer of computer input devices such as keyboards, mice, microphones, and headsets for applications in office, gaming, and industry for hybrid work, as well as hardware and software solutions in digital healthcare. Since its founding in 1953, CHERRY has been synonymous with innovative and durable high-quality products, developed in-house, specifically to meet customer needs.

CHERRY’s operational headquarters is in Germany (Auerbach in der Oberpfalz) and it employs staff in development, services, logistics, and production sites in Germany (Auerbach), China (Zhuhai), and Austria (Vienna), as well as in multiple sales offices in Germany (Munich, Auerbach), France (Paris), Sweden (Landskrona), the USA (Chicago), China (Shanghai) and Taiwan (Taipei).

For more information, visit:https://ir.cherry.de/en/


Contact

Cherry SE
Nicole Schillinger
Investor Relations
P: Rosental 7, c/o Mindspace, 80331 Munich
T: +49 (0) 9643 2061 848
E: ir@cherry.de



14.05.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Cherry SE
Rosental 7, c/o Mindspace
80331 Munich
Germany
ISIN: DE000A3CRRN9
WKN: A3CRRN
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2137520

 
End of News EQS News Service

2137520  14.05.2025 CET/CEST

Visual performance / price development - Cherry SE
Smart analysis and research tools can be found here.
MIC: XETR

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2025
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.